Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation — Ryosuke Tateishi (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
Shared by
Masatoshi Kudo
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
Article
2018
en
Authors
+12 more
RT
Ryosuke Tateishi
MS
Masataka Seike
Masatoshi Kudo
Abstract
1 min read
The study is registered at JapicCTI-121944.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
Hisashi Hidaka
,
Masayuki Kurosaki
,
Hironori Tanaka
,
Masatoshi Kudo
,
Seigo Abiru
,
Takumi Igura
,
Toru Ishikawa
,
Masataka Seike
,
Takayuki Katsube
,
Toshimitsu Ochiai
,
Kazuhiro Kimura
,
Takahiro Fukuhara
,
Takeshi Kano
,
Tsutae Den Nagata
,
Katsuaki Tanaka
,
Mineo Kurokawa
,
Kazuhide Yamamoto
,
Yukio Osaki
,
Namiki Izumi
,
Michio Imawari
Dataset
Supplementary Material for: Surgery Versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: a Randomized Controlled Trial (SURF-Trial)
Tadatoshi Takayama
,
Kiyoshi Hasegawa
,
Namiki Izumi
,
Masatoshi Kudo
,
Mitsuo Shimada
,
N. Yamanaka
,
M. Inomata
,
Shuichi Kaneko
,
Hisashi Nakayama
,
Y. Kawaguchi
,
Kosuke Kashiwabara
,
Ryosuke Tateishi
,
Shuichiro Shiina
,
Kazuhiko Koike
,
Y. Matsuyama
,
Masao Omata
,
Masatoshi Makuuchi
,
Norihiro Kokudo
Article
2021
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial)
Tadatoshi Takayama
,
Kiyoshi Hasegawa
,
Namiki Izumi
,
Masatoshi Kudo
,
Mitsuo Shimada
,
Naoki Yamanaka
,
Masafumi Inomata
,
Shuichi Kaneko
,
Hisashi Nakayama
,
Yoshikuni Kawaguchi
,
Kosuke Kashiwabara
,
Ryosuke Tateishi
,
Shuichiro Shiina
,
Kazuhiko Koike
,
Yutaka Matsuyama
,
Masao Omata
,
Masatoshi Makuuchi
,
Norihiro Kokudo
Article
2021
A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival.
Masatoshi Kudo
,
Kiyoshi Hasegawa
,
Yoshikuni Kawaguchi
,
Tadatoshi Takayama
,
Namiki Izumi
,
Naoki Yamanaka
,
Mitsuo Shimada
,
Masahumi Inomata
,
Shuichi Kaneko
,
Hideo Baba
,
Kazuhiko Koike
,
Masao Omata
,
Masatoshi Makuuchi
,
Yutaka Matsuyama
,
Norihiro Kokudo
Article
2020
A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma
Masatoshi Kudo
,
Manabu Morimoto
,
Michihisa Moriguchi
,
Namiki Izumi
,
Tetsuji Takayama
,
Hitoshi Yoshiji
,
Keisuke Hino
,
Takayoshi Oikawa
,
Tetsuhiro Chiba
,
Kenta Motomura
,
Junko Kato
,
Kentaro Yasuchika
,
Akio Ido
,
Takashi Sato
,
Daisuke Nakashima
,
Kazuomi Ueshima
,
Masafumi Ikeda
,
Takuji Okusaka
,
Kazuo Tamura
,
Junji Furuse
Discussion(0)
No comments yet. Be the first to comment.